Mycobacterium tuberculosis, autoimmunity, and vitamin D

Clinical Reviews in Allergy and Immunology

Volumn 38, Issue 2-3, 2010, Pages 169-177

  Shapira, Yinon ^a   Agmon Levin, Nancy ^a   Shoenfeld, Yehuda ^a,b  

^a SHEBA MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Autoimmune disease; Innate immunity; Mycobacterium tuberculosis; TB; Vitamin D; Vitamin dreceptor

Indexed keywords

ANTINUCLEAR ANTIBODY; BCG VACCINE; CARDIOLIPIN ANTIBODY; COLECALCIFEROL; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; DNA ANTIBODY; DOUBLE STRANDED DNA ANTIBODY; NEUTROPHIL CYTOPLASMIC ANTIBODY; PLACEBO; RHEUMATOID FACTOR; RIBONUCLEOPROTEIN ANTIBODY; RO ANTIBODY; SM ANTIBODY; TUBERCULOSTATIC AGENT; VITAMIN D;

ADAPTIVE IMMUNITY; AUTOIMMUNE DISEASE; AUTOIMMUNITY; BACTERIAL IMMUNITY; BCG VACCINATION; CLINICAL TRIAL; COLITIS; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG MEGADOSE; HUMAN; IMMUNOMODULATION; INNATE IMMUNITY; INSULIN DEPENDENT DIABETES MELLITUS; LUNG TUBERCULOSIS; MULTIPLE SCLEROSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIMARY PREVENTION; REVIEW; RHEUMATOID ARTHRITIS; SINGLE DRUG DOSE; SYSTEMIC LUPUS ERYTHEMATOSUS; TUBERCULOSIS; TUBERCULOUS ARTHRITIS; UNSPECIFIED SIDE EFFECT; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION;

ANIMALS; ANTITUBERCULAR AGENTS; AUTOIMMUNE DISEASES; AUTOIMMUNITY; HUMANS; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS; VITAMIN D;

EID: 77953321222     PISSN: 10800549     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12016-009-8150-1     Document Type: Review

References (149)

1. Koch R (1882) Die aetiologie der tuberculose. Berl Klinische Wochenschr 19:221-230
2. Mathema B, Kurepina N, Bifani P, Kreiswirth B (2006) Molecular epidemiology of tuberculosis: current insights. Clin Microbiol Rev 19:658-685
3. Maartens G, Wilkinson R (2007) Tuberculosis. Lancet 370:2030-2043
4. WHO (2008) Global tuberculosis control: surveillance, planning, financing: WHO report. WHO, Geneva WHO/HTM/TB/2008.393
5. Dye C, Scheele S, Dolin P, Pathania V, Raviglione M (1999) Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country [consensus statement]. WHO Global Surveillance and Monitoring Project. JAMA 282:677-686
6. Comstock GW (1982) Epidemiology of tuberculosis. Am Rev Respir Dis 125:128
7. Iseman M, Madsen L (1989) Drug-resistant tuberculosis. Clin Chest Med 10:341-353
8. WHO (2008) Anti-tuberculosis drug resistance in the world: WHO Fourth Global Report. WHO, Geneva WHO/HTM/TB/2008.394
9. Harel M, Shoenfeld Y (2006) Predicting and preventing autoimmunity, myth or reality? Ann NYAcad Sci 1069:322-345
10. Shoenfeld Y, Isenberg DA (1989) The mosaic of autoimmunity. Immunol Today 10:123-126
11. Shoenfeld Y, Blank M, Abu-Shakra M, Amital H, Barzilai O, Berkun Y, Bizzaro N, Gilburd B, Zandman-Goddard G, Katz U, Krause I, Langevitz P, Mackay IR, Orbach H, Ram M, Sherer Y, Toubi E, Gershwin ME (2008) The mosaic of autoimmunity: prediction, autoantibodies, and therapy in autoimmune diseases. Isr Med Assoc J 10:13-19 (Pubitemid 351649456)
12. Shoenfeld Y, Zandman-Goddard G, Stojanovich L, Cutolo M, Amital H, Levy Y, Abu-Shakra M, Barzilai O, Berkun Y, Blank M, de Carvalho JF, Doria A, Gilburd B, Katz U, Krause I, Langevitz P, Orbach H, Pordeus V, Ram M, Toubi E, Sherer Y (2008) The mosaic of autoimmunity: hormonal and environmental factors involved in autoimmune diseases. Isr Med Assoc J 10:8-12 (Pubitemid 351649455)
13. Shoenfeld Y, Gilburd B, Abu-Shakra M, Amital H, Barzilai O, Berkun Y, Blank M, Zandman-Goddard G, Katz U, Krause I, Langevitz P, Levy Y, Orbach H, Pordeus V, Ram M, Sherer Y, Toubi E, Tomer Y (2008) The mosaic of autoimmunity: genetic factors involved in autoimmune diseases. Isr Med Assoc J 10:3-7
14. Shoenfeld Y, Isenberg D (1988) Mycobacteria and autoimmunity. Immunol Today 9:178-182
15. Elkayam O, Caspi D, Lidgi M, Segal R (2007) Auto-antibody profiles in patients with active pulmonary tuberculosis. Int j Tuberc Lung Dis 11:306-310 (Pubitemid 46447439)
16. Adams J, Hewison M (2008) Unexpected actions of vitamin-D: new perspectives on the regulation of innate and adaptive immunity. Nat Clin Pract Endocrinol Metab 4:80-90
17. Arnson Y, Amital H, Shoenfeld Y (2007) Vitamin-D and autoimmunity: new aetiological and therapeutic considerations. Ann Rheum Dis 66:1137-1142
18. Martineau A, Wilkinson R, Katalin A, Wilkinson R et al (2007) A single dose of vitamin-D enhances immunity to mycobacteria. Am J Respir Crit Care Med 176:208-213
19. Nursyam E, Amin Z, Rumende C (2006) The effect of vitamin-D as supplementary treatment in patients with moderately advanced pulmonary tuberculous lesion. Acta Med Indones 38:3-5
20. Institute of Medicine (1997) Dietary reference intakes for calcium, magnesium, phosphorus, vitamin-D, and fluoride. National Academy, Washington, DC
21. Holick M (2007) Vitamin-D deficiency. N Engl J Med 357:266-281
22. Gibney KB, MacGregor L, Leder K et al (2008) Vitamin D deficiency is associated with tuberculosis and latent tuberculosis infection in immigrants from sub-Saharan Africa. Clin Infect Dis 46:443-446
23. Holick M, Chen T (2008) Vitamin-D deficiency: a worldwide problem with health consequences. Am J Clin Nutr 87:1080S-1086S
24. Holick M (2008) Deficiency of sunlight and vitamin-D. BMJ 336:1318-1319
25. Zittermann A (2003) Vitamin-D in preventive medicine: are we ignoring the evidence? Br J Nutr 89:552-572
26. Strachan D, Powell K, Thaker A, Millard F, Maxwell J (1995) Vegetarian diet as a risk factor for tuberculosis in immigrant south London Asians. Thorax 50:175-180
27. Nnoaham K, Clarke A (2008) Low serum vitamin-D levels and tuberculosis: a systematic review and meta-analysis. Int J Epidemiol 37:113-119
28. Sita-Lumsden A, Lapthorn G, Swaminathan R, Milburn H (2007) Reactivation of tuberculosis and vitamin-D deficiency: the contribution of diet and exposure to sunlight. Thorax 62:1003-1007
29. Bellamy R, Ruwende C, Corrah T, McAdam K et al (1999) Tuberculosis and chronic hepatitis B virus infection in Africans and variation in the vitamin-D receptor gene. J Infect Dis 179:721-724
30. Selvaraj P, Chandra G, Kurian S, Reetha A, Narayanan P (2003) Association of vitamin-D receptor gene variants of Bsm I, Apa I and Fok I polymorphisms with susceptibility or resistance to pulmonary tuberculosis. Curr Sci 84:1564-1568
31. Bornman L, Campbell S, Fielding K et al (2004) Vitamin-D receptor polymorphisms and susceptibility to tuberculosis in West Africa: a case-control and family study. J Infect Dis 190:1631-1641
32. Wilbur A, Kubatko L, Hurtado A, Hill K (2007) Stone A. Vitamin-D receptor gene polymorphisms and susceptibility M. tuberculosis in Native Paraguayans. Tuberculosis 87:329-337
33. Lewis S, Baker I, Davey S (2005) Meta-analysis of vitamin-D receptor polymorphisms and pulmonary tuberculosis risk. Int J Tuberc Lung Dis. 9:1174-1177
34. Wilkinson R, Llewelyn M, Toossi Z, Patel P et al (2000) Influence of vitamin-D deficiency and vitamin-D receptor polymorphisms on susceptibility to tuberculosis amongst Gujarati Asians in west London: a case-control study. Lancet 355:618-621
35. Selvaraj P, Alagarasu K, Harishankar M, Vidyarani M, Narayanan P (2008) Regulatory region polymorphisms of vitamin-D receptor gene in pulmonary tuberculosis patients and normal healthy subjects of south India. Int J Immunogenetics 35:251-254
36. Ralph A, Kelly P, Anstey N (2008) L-arginine and vitamin-D: novel adjunctive immunotherapies in tuberculosis. Trends Microbiol 16(7):336-344
37. Williams CJB (1849) Cod liver oil in phthisis. London J Med 1:1-18
38. Charpy J (1950) Quelques traitments vitaminés ou par substances fonctionelles en dermatologie. Bull Méd 24:505
39. Martineau A, Honecker F, Wilkinson R, Griffiths C (2007) Vitamin-D in the treatment of pulmonary tuberculosis. J Steroid Biochem Mol Biol 103:793-798
40. Liu P, Krutzik S, Modlin R (2007) Therapeutic implications of the TLR and VDR partnership. Trends Mol Med 13:117-124
41. Cosma C, Sherman D, Ramakrishnan L (2003) The secret lives of the pathogenic mycobacteria. Annu Rev Microbiol 57:641-676
42. Rook G, Steele J, Fraher L et al (1986) Vitamin-D3, γ interferon, and control of proliferation of Mycobacterium tuberculosis by human monocytes. Immunology 57:159-163
43. Crowle A, Ross E, May M (1987) Inhibition by 1, 25(OH)2-vitamin D3 of the multiplication of virulent tubercle bacilli in cultured human macrophages. Infect Immun 55:2945-2950
44. Liu P, Stenger S, Wenzel H et al (2006) Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 311:1770-1773
45. Adams J (2006) Vitamin-D as a defensin. J Musculoskelet Neuronal Interact 6:344-346
46. Martineau A, Wilkinson K, Newton S et al (2007) IFN-γ- and TNF-independent vitamin-D-inducible human suppression of mycobacteria: the role of cathelicidin LL-37. J Immunol 178:7190-7198
47. Liu P, Stenger S, Tang D, Modli R (2007) Cutting edge: Vitamin-D-mediated human antimicrobial activity against Mycobacterium tuberculosis is dependent on the induction of cathelicidin. J Immunol 179:2060-2063
48. Brightbill H, Libraty D, Krutzik S et al (1999) Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors. Science 285:732-736
49. Centers for Disease Control and Prevention (CDC) (2007) Trends in tuberculosis - United States. MMWR Morb Mortal Wkly Rep 57:281-285 2008
50. Ferrari G, Langen H, Naito M, Pieters J (1999) A coat protein on phagosomes involved in the intracellular survival of mycobacteria. Cell 97:435-447
51. Pieters J (2001) Evasion of host cell defense mechanisms by pathogenic bacteria. Curr Opin Immunol 13:37-44
52. Anand P, Kaul D (2003) Vitamin-D3-dependent pathway regulates TACO gene transcription. Biochem Biophys Res Commun 310:876-877
53. Anand P, Kaul D, Sharma M (2008) Synergistic action of vitamin-D and retinoic acid restricts invasion of macrophages by pathogenic mycobacteria. J Microbiol Immunol Infect 41:17-25
54. Watts H, Lifeso R (1996) Tuberculosis of bones and joints. J Bone Joint Surg Am 78:288-298
55. Hugosson C, Nyman R, Brismar J et al (1996) Imaging of tuberculosis. Peripheral osteoarticular and soft tissue tuberculosis. Acta Radiol 37:512-516
56. Franco-Paredes C, Díaz-Borjon A, Senger M, Barragan L, Leonard M (2006) The ever-expanding association between rheumatologic diseases and tuberculosis. Am J Med 119:470-477
57. Arthanari S, Yusuf S, Nisar M (2008) Tuberculosis of the knee complicating seronegative arthritis. J Rheumatol 35:1227-1228
58. Kakourou T, Drosatou P, Psychou F, Aroni K, Nicolaidou P (2001) Erythema nodosum in children: a prospective study. J Am Acad Dermatol. 44:17-21
59. Lowry K, Stephan K, Davis C (1999) Miliary tuberculosis presenting with rigors and developing unusual cutaneous manifestations. Cutis 64:23-28
60. Elkayam O, Segal R, Lidgi M, Caspi D (2006) Positive anti-cyclic citrullinated proteins and rheumatoid factor during active lung tuberculosis. Ann Rheum Dis 65:1110-1112
61. Teplizki H, Buskila D, Isenberg DA, Coates ARM, Sukenik S, Horowitz J, Shoenfeld Y (1987) Low serum anti-TB glycolipid antibodies titer in the sera of patients with SLE as an indicator of CNS involvement. J Rheumatol 14:507-511
62. Zandman-Goddard G, Shoenfeld Y (2005) Infections and SLE. Autoimmunity 38:473-485
63. Shoenfeld Y, Schwartz R (1984) Immunologic and genetic factors in autoimmune diseases. N Eng J Med 311:1019-1029
64. Blank M, Barzilai O, Shoenfeld Y (2007) Molecular mimicry and auto-immunity. Clin Rev Allergy Immunol 32:111-118
65. Doria A, Canova M, Tonon M, Zen M et al (2008) Infections as triggers and complications of systemic lupus erythematosus. Autoimmun Rev 8:24-28
66. Ortega-Hernandez OD, Agmon-Levin N, Blank M, Asherson RA, Shoenfeld Y (2009) The physiopathology of the catastrophic antiphospholipid (Asherson's) syndrome: compelling evidence. J Autoimmun 32:1-6
67. Shoenfeld Y, Vilner Y, Coates A, Rauch J, Lavie G, Shaull D, Pinkhas J (1986) Monoclonal antituberculosis antibodies react with DNA, and monoclonal anti-DNA autoantibodies react with Mycobacterium tuberculosis. Clin Exp Immunol 66:255-261
68. Holoshitz J, Koning F, Coligan J et al (1989) Isolation of CD4-CD8-mycobacteria-reactive T lymphocyte clones from rheumatoid arthritis synovial fluid. Nature 339:226-229
69. Holoshitz J, Klajman A, Drucker I et al (1986) T lymphocytes of rheumatoid arthritis patients show augmented reactivity to a fraction of mycobacteria cross-reactive with cartilage. Lancet 2:305-309
70. Pope R, Wallis R, Sailer D et al (1991) T cell activation by mycobacterial antigens in inflammatory synovitis. Cell Immunol 133:95-108
71. Haftel H, Chang Y, Hinderer R et al (1994) Induction of the autoantigen proliferating cell nuclear antigen in T lymphocytes by a microbacterial antigen. Clin Invet 94:1365-1372
72. George J, Shoenfeld Y, Gilburd B, Afek A, Shaish A, Harats D (2000) Requisite role for interleukin-4 in the acceleration of fatty streaks induced by heat shock protein 65 or Mycobacterium tuberculosis. Circ Res 86:1203-1210
73. Winfield J (1989) Stress proteins, arthritis, and autoimmunity. Arthritis Rheum 32:1497-1504
74. Jones D, Hunter N, Duff G (1990) Heat shock protein 65 as a β cell antigen of insulin dependent diabetes. Lancet 336:583-585
75. Xu Q, Willeit J, Marosi M, Kleindienst R et al (1993) Association of serum antibodies to heat shock protein 65 with carotid atherosclerosis. Lancet 341:255-259
76. Perschinka H, Mayr M, Millonig G et al (2003) Cross-reactive B-cell epitopes of microbial and human heat shock protein 60/65 in atherosclerosis. Arterioscler Thromb Vasc Biol 23:1060-1065
77. Zhu J, Quyyumi A, Rott D et al (2001) Antibodies to human heat-shock protein 60 are associated with the presence and severity of coronary artery disease: evidence for an autoimmune component of atherogenesis. Circulation 103:1071-1075
78. George J, Shoenfeld Y, Afek A, Gilburd B, Keren P, Shaish A, Kopolovic Y, Wick G, Harats D (1999) Enhanced fatty streak formation in C57BL/6J mice by immunization with heat shock protein 65. Arterioscler Thromb Vasc Biol 19:505-510
79. Harats D, Yacov N, Gilburd B, Shoenfeld Y, George J (2002) Oral tolerance with heat shock protein 65 attenuates mycobacterium tuberculosis-induced and high-fat-diet-driven atherosclerotic esions. JACC 40:1333-1338
80. Res P, Schaar C, Breedveld F et al (1988) Synovial fluid T cell reactivity against 65 kD heat shock protein of mycobacteria in early chronic arthritis. Lancet 27:478-480
81. Tasneem S, Islam N, Ali R (2001) Crossreactivity of SLE autoantibodies with 70 kDa heat shock proteins of Mycobacterium tuberculosis. Microbiol Immunol 45:841-846
82. Salvetti M, Buttinelli C, Ristori G et al (1992) T lymphocyte reactivity to the recombinant mycobacterial 65- and 70-kD heat shock proteins in multiple sclerosis. J Autoimmun 5:691-702
83. Salvetti M, Ristori G, Buttinelli C et al (1996) The immune response to mycobacterial 70 kDa heat shock proteins frequently involves autoreactive T cells and is quantitatively disregulated in multiple sclerosis. J Neuroimmunol 65:143-153
84. Alard J, Dueymes M, Youinou P, Jamin C (2007) Modulation of endothelial cell damages by anti-Hsp60 autoantibodies in systemic autoimmune diseases. Autoimmun Rev 6:438-443
85. Gilbertson B, Germano S, Steele P et al (2004) Bystander activation of CD8+ T lymphocytes during experimental mycobacterial infection. Infect Immun 72:6884-6891
86. Salgame P (2005) Host innate and Th1 responses and the bacterial factors that control Mycobacterium tuberculosis infection. Curr Opin Immunol 17:374-380
87. Baccala R, Kono D, Theofilopoulos A (2005) Interferons as pathogenic effectors in autoimmunity. Immunol Rev 204:9-26
88. Gardam M, Keystone E, Menzies R et al (2003) Anti-tumour necrosis factor agents and tuberculosis risk: mechanisms of action and clinical management. Lancet Infect Dis 3:148-155
89. Keane J, Gershon S, Wise R et al (2001) Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med 345:1098-1104
90. Tincani A, Andreoli L, Bazzani C, Bosiso D, Sozzani S (2007) Inflammatory molecules: a target for treatment of systemic autoimmune diseases. Autoimmun Rev 7:1-7
91. Leadbetter E, Rifkin A, Hohlbaum A, Beaudette B et al (2002) Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 416:603-607
92. Rifkin I, Leadbetter E, Busconi L, Viglianti G, Marshak-Rothstein A (2005) Toll-like receptors, endogenous ligands, and systemic autoimmune disease. Immunol Rev 204:27-42 (Pubitemid 40460491)
93. Eriksson U et al (2003) Dendritic cell-induced autoimmune heart failure requires cooperation between adaptive and innate immunity. Nat Med 9:1484-1490
94. Waldner H, Collins M, Kuchroo V (2004) Activation of antigen-presenting cells by microbial products breaks self tolerance and induces autoimmune disease. J Clin Invest 113:990-997
95. Deng G, Nilsson I, Verdrengh M et al (1999) Intra-articularly localized bacterial DNA containing CpG motifs induces arthritis. Nat Med 5:702-705
96. Segal B, Chang J, Shevach E (2000) CpG oligonucleotides are potent adjuvants for the activation of autoreactive encephalitogenic T cells in vivo. J Immunol 164:5683-5688
97. Lang K, Recher M, Junt T et al (2005) Toll-like receptor engagement converts T-cell autoreactivity into overt autoimmune disease. Nat Med 11:138-145
98. Nishikubo K, Imanaka-Yoshida K, Tamaki S et al (2007) Th1-type immune responses by Toll-like receptor 4 signaling are required for the development of myocarditis in mice with BCG-induced myocarditis. J Autoimmun 29:146-153
99. Silver K, Crockford T, Bouriez-Jones T et al (2007) MyD88-dependent autoimmune disease in Lyn-deficient mice. Eur J Immunol 37:2734-2743
100. Sadanaga A, Nakashima H, Akahoshi M et al (2007) Protection against autoimmune nephritis in MyD88-deficient MRL/lpr mice. Arthritis Rheum 56:1618-1628
101. Mansell A, Brint E, Gould J et al (2004) Mal interacts with tumor necrosis factor receptor-associated factor (TRAF)-6 to mediate NF-kappaB activation by toll-like receptor (TLR)-2 and TLR4. J Biol Chem 279:37227-37230
102. Reiling N, Holscher C, Fehrenbach A et al (2002) Cutting edge: Toll-like receptor (TLR)2- and TLR4-mediated pathogen recognition in resistance to airborne infection with Mycobacterium tuberculosis. J Immunol 169:3480-3484
103. Castiblanco J, Varela D, Castaño-Rodríguez N, Rojas-Villarraga A, Hincapié M, Anaya J (2008) TIRAP (MAL) S180L polymorphism is a common protective factor against developing tuberculosis and systemic lupus erythematosus. Infect Genet Evol 8:541-544
104. Pearson C (1956) Development of arthritis, periarthritis, and periostitisin rats given adjuvant. Proc Soc Exp Biol Med 91:95-101
105. Holoshitz J, Matitiahu A, Cohen I (1984) Arthritis induced in rats by cloned T-lymphocytes responsive to mycobacteria but not to collagen type II. J clin Invest 73:211-215
106. Torisu M, Miyahara T, Shinohara N et al (1978) A new side effect of BCG immunotherapy: BCG-induced arthritis in man. Cancer Immunol Immunother 5:77-83
107. Orbach H, Zandman-Goddard G, Amital H, Barak V, Szekanecz Z, Szucs G, Danko K, Nagy E, Csepany T, Carvalho JF, Doria A, Shoenfeld Y (2007) Novel biomarkers in autoimmune diseases: prolactin, ferritin, vitamin-D, and TPA levels in autoimmune diseases. Ann N Y Acad Sci 1109:385-400
108. Carvalho JF, Blank M, Kiss E, Tarr T, Amital H, Shoenfeld Y (2007) Anti-vitamin-D, vitamin-D in SLE: preliminary results. Ann N Y Acad Sci 1109:550-557
109. Cantorna M, Zhu Y, Froicu M, Wittke A (2004) Vitamin-D status, 1, 25-dihydroxyvitamin-D3, and the immune system. Am J Clin Nutr 80:1717S-1720S
110. Ponsonby A-L, McMichael A, van der Mei I (2002) Ultraviolet radiation and autoimmune disease: insights from epidemiological research. Toxicology 181-182:71-78
111. Pappa H, Gordon C, Saslowsky T et al (2006) Vitamin D status in children and young adults with inflammatory bowel disease. Pediatrics 118:1950-1961
112. Nieves J, Cosman F, Herbert J, Shen V, Lindsay R (1994) High prevalence of vitamin-D deficiency and reduced bone mass in multiple sclerosis. Neurology 44:1687-1692
113. Aguado P, del Campo M, Garces M et al (2000) Low vitamin-D levels in outpatient postmenopausal women from a rheumatology clinic in Madrid, Spain: their relationship with bone mineral density. Osteoporos Int 11:739-744
114. Kamen D, Cooper G, Bouali H et al (2006) Vitamin-D deficiency in systemic lupus erythematosus. Autoimmun Rev 5:114-117 (Pubitemid 43129539)
115. Munger K, Levin L, Hollis B, Howard N, Ascherio A (2006) Serum 25-hydroxyvitamin-D levels and risk of multiple sclerosis. JAMA 296:2832-2838
116. Abe J, Nakamura K, Takita Y, Nakano T, Irie H, Nishii Y (1990) Prevention of immunological disorders in MRL/l mice by a new synthetic analogue of vitamin D3: 22-oxa-1 alpha,25-dihydroxyvitamin-D3. J Nutr Sci Vitaminol 36:21-31
117. Daniel C, Radeke H, Sartory N et al (2006) The new low calcemic vitamin-D analog 22-ene-25-oxa-vitamin-D prominently ameliorates Th1-mediated colitis in mice. J Pharmacol Exp Ther 319:622-631
118. Cantorna M, Hayes C, DeLuca H (1996) 1, 25-Dihydroxyvitamin-D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis. Proc Natl Acad Sci U S A 93:7861-8764
119. Cantorna M, Humpal-Winter J, DeLuca H (1999) Dietary calcium is a major factor in 1, 25-dihydroxycholecalciferol suppression of experimental autoimmune encephalomyelitis in mice. J Nutr 129:1966-1971
120. Mathieu C, Waer M, Laureys J, Rutgeerts O, Bouillon R (1994) Prevention of autoimmune diabetes in NOD mice by 1,25 dihydroxyvitamin-D3. Diabetologia 37:552-558
121. Munger K, Zhang S, O'Reilly E et al (2004) Vitamin-D intake and incidence of multiple sclerosis. Neurology 62:60-65
122. Merlino L, Curtis J, Mikuls T et al (2004) Vitamin-D intake is inversely associated with rheumatoid arthritis: results from the Iowa Women's Health Study. Arthritis Rheum 50:72-77
123. Cutolo M, Otsa K, Uprus M, Paolino S, Seriolo B (2007) Vitamin D in rheumatoid arthritis. Autoimmun Rev 7:59-64
124. Goldberg P, Fleming M, Picard E (1986) Multiple sclerosis: decreased relapse rate through dietary supplementation with calcium, magnesium and vitamin-D. Med Hypotheses 21:193-200
125. Birlea S, Costin G, Norris D (2008) Cellular and molecular mechanisms involved in the action of vitamin-D analogs targeting vitiligo depigmentation. Curr Drug Targets 9:345-359
126. Hypponen E, Laara E, Reunanen A, Jarvelin M, Virtanen S (2001) Intake of vitamin D and risk of type 1 diabetes: a birthcohort study. Lancet 358:1500-1503
127. Bhalla A, Amento E, Clemens T et al (1983) Specific high-affinity receptors for 1, 25-dihydroxyvitamin-D3 in human peripheral blood mononuclear cells: presence in monocytes and induction in T lymphocytes following activation. J Clin Endocrinol Metab 57:1308-1310
128. Provvedini D, Tsoukas C, Deftos L, Manolagas S (1986) 1 alpha, 25-Dihydroxyvitamin-D3-binding macromolecules in human B lymphocytes: effects on immunoglobulin production. J Immunol 136:2734-2740
129. Chen S, Sims GP, Chen X et al (2007) Modulatory effects of 1, 25-dihydroxyvitamin-D3 on human B cell differentiation. J Immunol 179:1634-1647
130. Doria A, Arienti S, Rampudda M, Canova M et al (2008) Preventive strategies in systemic lupus erythematosus. Autoimmun Rev 7:192-197
131. Overbergh L, Decallonne B, Waer M et al (2000) 1alpha, 25-dihydroxyvitamin-D3 induces an autoantigen-specific T-helper 1/T-helper 2 immune shift in NOD mice immunized with GAD65 (p524-543). Diabetes 49:1301-1307
132. Bhalla A, Amento E, Serog B, Glimcher L (1984) 1, 25-Dihydroxyvitamin-D3 inhibits antigen-induced T cell activation. J Immunol 133:1748-1754
133. Lemire J (1992) Immunomodulatory role of 1, 25-dihydroxyvitamin-D3. J Cell Biochem 49:26-31
134. Lemire J, Archer D, Beck L, Spiegelberg H (1995) Immunosup-pressive actions of 1, 25-dihydroxyvitamin-D3: preferential inhibition of Th1 functions. J Nutr 125:1704S-1708S
135. van Etten E, Mathieu C (2005) Immunoregulation by 1,25-dihydroxyvitamin- D3: basic concepts. J Steroid Biochem Mol Biol 97:93-101
136. Ramos-Lopez E, Jansen T, Ivaskevicius V et al (2006) Protection from type 1 diabetes by vitamin-D receptor haplotypes. Ann N Y Acad Sci 1079:327-334
137. Bailey R, Cooper J, Zeitels L et al (2007) Association of the vitamin-D metabolism gene CYP27B1 with type 1 diabetes. Diabetes 56:2616-2621
138. Huang C, Wu M, Wu J, Tsai F (2002) Association of vitamin-D receptor gene BsmI polymorphisms in Chinese patients with systemic lupus erythematosus. Lupus 11:31-34 (Pubitemid 34178117)
139. Shimada A, Kanazawa Y, Motohashi Y et al (2008) Evidence for association between vitamin D receptor BsmI polymorphism and type 1 diabetes in Japanese. J Autoimmun 30:207-211
140. Penna G, Amuchastegui S, Cossetti C et al (2006) Treatment of experimental autoimmune prostatitis in nonobese diabetic mice by the vitamin-D receptor agonist elocalcitol. J Immunol 177:8504-8511
141. Penna G, Adorini L (2000) 1α,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J Immunol 164:2405-2411
142. Adorini L, Giarratana N, Penna G (2004) Pharmacological induction of tolerogenic dendritic cells and regulatory T cells. Semin Immunol 16:127-134
143. Luciano A, Giuseppe P (2008) Control of autoimmune diseases by the vitamin D endocrine system. Nat Clin Pract Rheumatol 4:404-412
144. Shoenfeld Y, Selmi C, Zimlichman E, Gershwin ME (2008) The autoimmunologist: geoepidemilogy, a new center of gravity, and prime time for autoimmunity. J Autoimmun 31:325-30
145. Adebajo A, Charles P, Maini R, Hazleman B (1993) Autoantibodies in malaria, tuberculosis and hepatitis B in a west African population. Clin Exp Immunol 92:73-76
146. Flores-Suarez LF, Cabiedes J, Villa AR, van der Woude FJ, Alcocer-Varela J (2003) Prevalence of antineutrophilic cytoplasmatic autoantibodies in patients with tuberculosis. Rheumatology 42:223-229
147. Sela O, el-Roeiy A, Isenberg DA, Kennedy RC, Colaco CB, Pinkhas J, Shoenfeld Y (1987) A common anti-DNA idiotype in sera of patients with active pulmonary tuberculosis. Arthritis Rheum 30:50-56
148. Isenberg D, Maddison P, Swana G (1987) Profile of autoantibodies in the serum of patients with tuberculosis, klebsiella and other Gram-negative infections. Clin Exp Immunol 67:516-523
149. Di Cesar D, Ploutz-Snyder R, Weinstock R, Moses A (2006) Vitamin D deficiency is more common in type 2 than in type 1 diabetes. Diabetes Care 29:174